Profile data is unavailable for this security.
About the company
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.
- Revenue in USD (TTM)65.00k
- Net income in USD-5.95m
- Incorporated2020
- Employees4.00
- LocationBullfrog AI Holdings, Inc.323 Ellington Blvd, Unit 317GAITHERSBURG 20878United StatesUSA
- Phone+1 (240) 658-6710
- Fax+1 (302) 531-3150
- Websitehttps://www.bullfrogai.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM ImmunoTech Inc | 202.00k | -28.96m | 20.51m | 26.00 | -- | 2.07 | -- | 101.52 | -0.595 | -0.595 | 0.0042 | 0.2084 | 0.0068 | -- | 0.1413 | 7,769.23 | -96.75 | -45.64 | -116.18 | -48.35 | 79.21 | -231.75 | -14,337.62 | -11,695.01 | -- | -- | 0.00 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| Lumos Pharma Inc | 1.53m | -37.13m | 20.62m | 33.00 | -- | 1.18 | -- | 13.52 | -4.59 | -4.59 | 0.1886 | 2.15 | 0.0332 | -- | 8.01 | 46,212.12 | -80.89 | -29.78 | -90.15 | -32.32 | -- | -- | -2,434.69 | -2,937.61 | -- | -- | 0.00 | -- | 34.67 | -30.31 | -9.57 | -- | -- | -- |
| Polypid Ltd | 0.00 | -24.25m | 20.70m | 59.00 | -- | 2.90 | -- | -- | -12.35 | -12.35 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -84.94 | -76.92 | -120.03 | -89.61 | -- | -- | -- | -- | -- | -28.72 | 0.5498 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
| Sol Gel Technologies Ltd | 1.55m | -27.24m | 20.89m | 36.00 | -- | 0.5407 | -- | 13.44 | -1.02 | -1.02 | 0.0574 | 1.39 | 0.0338 | -- | 0.3774 | 43,166.67 | -59.27 | -31.60 | -64.80 | -35.49 | -- | -- | -1,752.77 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
| Neurosense Therapeutics Ltd | 0.00 | -11.28m | 20.97m | 16.00 | -- | -- | -- | -- | -0.7625 | -0.7625 | 0.00 | -0.1219 | 0.00 | -- | -- | 0.00 | -207.24 | -- | -395.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.59 | -- | -- | -- |
| MEI Pharma Inc | 66.75m | 26.16m | 20.99m | 46.00 | 0.8025 | 0.4113 | 0.7917 | 0.3144 | 3.93 | 3.93 | 10.02 | 7.66 | 0.6498 | -- | 29.15 | 1,451,174.00 | 25.46 | -25.31 | 30.38 | -28.59 | -- | -- | 39.18 | -122.05 | -- | -- | 0.00 | -- | 19.95 | 97.56 | 41.53 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 38.83m | -8.42m | 21.43m | 91.00 | -- | 0.7778 | -- | 0.5519 | -0.596 | -0.596 | 2.72 | 1.94 | 0.4542 | 0.8812 | 3.08 | 426,654.70 | -9.83 | -7.03 | -14.07 | -9.52 | 83.54 | 79.95 | -21.65 | -17.64 | 1.21 | -37.10 | 0.3717 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Forte Biosciences Inc | 0.00 | -32.14m | 21.90m | 11.00 | -- | 0.7625 | -- | -- | -1.03 | -1.03 | 0.00 | 0.7882 | 0.00 | -- | -- | 0.00 | -93.54 | -72.06 | -104.30 | -82.27 | -- | -- | -- | -491,850.00 | -- | -- | 0.00 | -- | -- | -- | -126.79 | -- | -46.29 | -- |
| Bioxytran Inc | 0.00 | -4.30m | 21.92m | 2.00 | -- | -- | -- | -- | -0.0297 | -0.0297 | 0.00 | -0.0017 | 0.00 | -- | -- | -- | -2,431.80 | -1,420.53 | -- | -- | -- | -- | -- | -- | -- | -7.69 | -- | -- | -- | -- | -73.71 | -- | -- | -- |
| Bullfrog AI Holdings, Inc. | 65.00k | -5.95m | 22.37m | 4.00 | -- | 3.29 | -- | 344.22 | -0.8903 | -0.8903 | 0.0097 | 0.8667 | 0.0094 | -- | -- | 16,250.00 | -85.49 | -- | -103.85 | -- | 92.00 | -- | -9,129.42 | -- | -- | -278.20 | 0.0694 | -- | 550.00 | -- | -91.11 | -- | -- | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 22.54m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Zivo Bioscience Inc | 63.37k | -7.08m | 22.60m | 8.00 | -- | -- | -- | 356.62 | -3.83 | -3.83 | 0.0318 | -0.8133 | 0.0652 | -- | -- | 7,921.25 | -728.52 | -376.60 | -- | -- | 38.05 | -- | -11,176.47 | -96,315.32 | -- | -88.46 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
| Neurobo Pharmaceuticals Inc | 0.00 | -16.58m | 22.86m | 8.00 | -- | 2.27 | -- | -- | -3.26 | -3.26 | 0.00 | 2.05 | 0.00 | -- | -- | 0.00 | -68.36 | -95.57 | -108.01 | -135.64 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 10.72 | -- | 75.54 | -- |
| Lisata Therapeutics Inc | 0.00 | -20.05m | 23.01m | 25.00 | -- | 0.5352 | -- | -- | -2.46 | -2.46 | 0.00 | 5.18 | 0.00 | -- | -- | 0.00 | -35.01 | -45.97 | -38.40 | -50.47 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 61.57 | -- | -- | -- |
| Iterum Therapeutics PLC | 0.00 | -35.58m | 23.34m | 14.00 | -- | -- | -- | -- | -2.64 | -2.64 | 0.00 | -- | -- | -- | -- | 0.00 | -- | -118.12 | -- | -199.23 | -- | -- | -- | -890,554.10 | -- | -- | -- | -- | -- | -- | 13.64 | -- | -32.09 | -- |
| Lyra Therapeutics Inc | 1.68m | -68.88m | 23.35m | 109.00 | -- | 0.3013 | -- | 13.90 | -1.23 | -1.23 | 0.0297 | 1.27 | 0.0143 | -- | -- | 19,090.91 | -58.52 | -58.01 | -68.02 | -68.69 | -- | -- | -4,099.82 | -6,235.31 | -- | -- | 0.00 | -- | 14.31 | 4.60 | -13.39 | -- | 95.14 | -- |
Data as of May 17 2024. Currency figures normalised to Bullfrog AI Holdings, Inc.'s reporting currency: US Dollar USD
2.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 87.66k | 1.12% |
| Fortem Financial Group LLCas of 31 Mar 2024 | 53.30k | 0.68% |
| Geode Capital Management LLCas of 31 Mar 2024 | 14.47k | 0.18% |
| Virtu Americas LLCas of 31 Dec 2023 | 14.15k | 0.18% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 8.12k | 0.10% |
| UBS Securities LLCas of 31 Mar 2024 | 2.52k | 0.03% |
| Tower Research Capital LLCas of 31 Mar 2024 | 2.22k | 0.03% |
| Bank of America, NA (Private Banking)as of 31 Mar 2024 | 100.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 22.00 | 0.00% |
| Global Retirement Partners LLCas of 31 Mar 2024 | 15.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
